BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26051797)

  • 1. Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay.
    Chieregato K; Alghisi A; Borghero C; Elice F; Raimondi R; Zanetti E; Rodeghiero F; Astori G
    Transfus Apher Sci; 2015 Oct; 53(2):242-5. PubMed ID: 26051797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.
    Taverna F; Coluccia P; Arienti F; Birolini A; Terranova L; Mazzocchi A; Rini F; Mariani L; Melani C; Ravagnani F
    J Clin Apher; 2015 Jun; 30(3):162-70. PubMed ID: 25220858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
    Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
    Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A; Salooja N; Russell-Jones R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
    Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
    Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology.
    Tsirigotis P; Kapsimalli V; Baltadakis I; Kaloyannidis P; Karakasis D; Papalexandri A; Psarra E; Nosi E; Konsta E; Vikentiou M; Papageorgiou S; Sakellari I; Pappa V; Harhalakis N; Anagnostopoulos A; Dervenoulas J
    Transfus Apher Sci; 2012 Apr; 46(2):181-8. PubMed ID: 22115608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
    Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
    Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.
    Bladon J; Taylor PC
    Br J Haematol; 1999 Dec; 107(4):707-11. PubMed ID: 10606873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy.
    Schmid D; Grabmer C; Streif D; Lener T; Schallmoser K; Rohde E
    Vox Sang; 2015 Jan; 108(1):82-8. PubMed ID: 25333914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFSE flow cytometric quantification of lymphocytic proliferation in extracorporeal photopheresis: use for quality control.
    Evrard B; Dosgilbert A; Jacquemot N; Demeocq F; Gilles T; Chassagne J; Berger M; Tridon A
    Transfus Apher Sci; 2010 Feb; 42(1):11-9. PubMed ID: 19931489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies.
    Abu-Dalle I; Reljic T; Nishihori T; Antar A; Bazarbachi A; Djulbegovic B; Kumar A; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1677-86. PubMed ID: 24867779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of extracorporeal photochemotherapy: Proliferation assay using CFSE validated according to ISO 15189:2007 standards.
    Faivre L; Lecouflet L; Liu WQ; Khadher I; Lahaie C; Vidal M; Legouvello S; Beaumont JL; Bierling P; Rouard H; Birebent B
    Cytometry B Clin Cytom; 2015 Jan; 88(1):30-9. PubMed ID: 25227323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis in solid organ transplant-associated acute graft-versus-host disease.
    Houston BL; Yan M; Tinckam K; Kamel-Reid S; Chang H; Kuo KH; Tsien C; Seftel MD; Avitzur Y; Grant D; Cserti-Gazdewich CM
    Transfusion; 2016 Apr; 56(4):962-9. PubMed ID: 26892365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD71 surface analysis of T cells: a simple alternative for extracorporeal photopheresis quality control.
    Schwab L; Michel G; Bein G; Hackstein H
    Vox Sang; 2020 Jan; 115(1):81-93. PubMed ID: 31680273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
    Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2018; 9():2207. PubMed ID: 30349527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
    Greinix HT; Worel N; Just U; Knobler R
    Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
    Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
    Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
    Bladon J; Taylor PC
    Transpl Int; 2006 Apr; 19(4):319-24. PubMed ID: 16573548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.